Skip to main content
. 2018 Mar 26;94(4):196–202. doi: 10.4174/astr.2018.94.4.196

Table 2. Comparison of survival between the dose reduction group and the standard group according to the administered dose of oxaliplatin.

graphic file with name astr-94-196-i002.jpg

OS, overall survival; DFS, disease-free survival.